학술논문
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study
Document Type
Artikel
Author
Source
Drug safety. 44(8):899-915
Subject
Language
English
English
English
ISSN
1179-1942